OPTIMIZATION OF MAINTENANCE DOSE WITH ECULIZUMAB ACCORDING TO WEIGHT IN PATIENTS WITH ATYPIC HAEMOLITHIC URINE MUSCLE SYNDROME
- Registry ID
- EUCTR2019-001619-21
- Source registry
- EUCTR
- Status
- Ongoing
- Phase
- PHASE4
- Sponsor
- HOSPITAL UNIVERSITARI DE BELLVITGE- IDIBELL
- Start date
- 2019-10-07
- Last update
- 2026-08-16
Conditions
- ATYPICAL HEMOLYTIC UREMIC SYNDROME
Summary
To explore the safety of dose adjustment of Eculizumab according to body weight in patients with aHUS in remission and in the maintenance phase.
Locations
View on source registry